Overview
Perforomist is a prescription drug first approved by the Food and Drug Administration (FDA) in 2001 for maintenance of asthma and prevention of bronchospasms in chronic obstructive pulmonary disease (COPD). Perforomist is not indicated for acute attacks. Perforomist may be referred to by its drug name, Formoterol. Formoterol is also marketed under the brand name Foradil.

Perforomist is a bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Perforomist is believed to work by relaxing smooth muscles in the airways. Perforomist is considered a long-acting bronchodilator.

How do I take it?
Perforomist is inh... read more

Perforomist (Formoterol) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in